APA (7th ed.) Citation

Ortega-Paz, L., Capodanno, D., & Angiolillo, D. J. (2021). Canakinumab for secondary prevention of coronary artery disease. Future cardiology, 17(3), 427-442. https://doi.org/10.2217/fca-2020-0211

Chicago Style (17th ed.) Citation

Ortega-Paz, Luis, Davide Capodanno, and Dominick J. Angiolillo. "Canakinumab for Secondary Prevention of Coronary Artery Disease." Future Cardiology 17, no. 3 (2021): 427-442. https://doi.org/10.2217/fca-2020-0211.

MLA (9th ed.) Citation

Ortega-Paz, Luis, et al. "Canakinumab for Secondary Prevention of Coronary Artery Disease." Future Cardiology, vol. 17, no. 3, 2021, pp. 427-442, https://doi.org/10.2217/fca-2020-0211.